|
Market Closed -
Nasdaq
01:30:00 07/10/2025 am IST
|
5-day change | 1st Jan Change | ||
| 5.670 USD | -.--% |
|
-.--% | - |
| 08/25/08 | MannKind Corporation completed the acquisition of scPharmaceuticals Inc.. | CI |
| 07/25/07 | MannKind Completes Acquisition of scPharmaceuticals | MT |
| Market Cap | 30Cr 27Cr 25Cr 23Cr 43Cr 2.92TCr 43Cr 300.65Cr 116.02Cr 1.49TCr 114.51Cr 111.97Cr 4.78TCr | P/E 2023 |
-4.41x | P/E 2024 | -1.85x |
|---|---|---|---|---|---|
| Enterprise Value | 28Cr 24Cr 23Cr 21Cr 39Cr 2.69TCr 40Cr 276.99Cr 106.89Cr 1.37TCr 105.5Cr 103.16Cr 4.41TCr | EV / Sales 2023 |
1,38,39,720x | EV / Sales 2024 | 42,15,542x |
| Free-Float |
98.42% | Yield 2023 * |
-
| Yield 2024 | - |
Last Transcript: scPharmaceuticals Inc.
| 1 year | 5.61 |  | 5.7 |
| 3 years | 1.94 | | 7.37 |
| 5 years | 1.94 | | 12.75 |
| 10 years | 1.94 | | 18.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Castagna
CEO | Chief Executive Officer | 49 | 07/10/2025 |
| Director of Finance/CFO | 50 | 07/10/2025 | |
David Thomson
SEC | Corporate Secretary | 59 | 07/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Castagna
BRD | Director/Board Member | 49 | 07/10/2025 |
David Thomson
BRD | Director/Board Member | 59 | 07/10/2025 |
| Director/Board Member | 50 | 07/10/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/10/25 | Tender | Chairman | 77,174 | 0.1542% | ||
| 07/10/25 | Tender | Director | 1,77,950 | 0.3556% | ||
| 07/10/25 | Issuer sale | Director | 72,174 | 0.1442% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | +0.71% | -22.22% | 30Cr | |
| +0.04% | +3.34% | +53.32% | +100.52% | 1,02800Cr | |
| -0.09% | +1.66% | +53.24% | +66.45% | 65TCr | |
| -0.02% | +2.66% | +18.65% | +71.97% | 47TCr | |
| -1.22% | +3.66% | +34.59% | +38.81% | 35TCr | |
| -0.79% | +2.73% | +17.73% | +25.11% | 27TCr | |
| +0.58% | +6.76% | +10.58% | +17.75% | 26TCr | |
| +1.55% | +2.20% | +35.12% | +45.91% | 21TCr | |
| +0.79% | +1.84% | -27.55% | -56.48% | 19TCr | |
| -0.52% | +4.45% | +31.57% | +98.11% | 19TCr | |
| Average | +0.03% | +2.93% | +22.80% | +38.59% | 36.02TCr | |
| Weighted average by Cap. | -0.04% | +3.09% | +34.84% | +61.59% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 13.59 11.85 11.19 10.16 19.04 1.3T 19.12 134.06 51.73 663.13 51.06 49.93 2.13T | 36.33 31.68 29.91 27.16 50.9 3.49T 51.11 358.33 138.28 1.77T 136.48 133.45 5.7T |
| Net income | -5.48Cr -4.78Cr -4.51Cr -4.1Cr -7.68Cr -525.93Cr -7.71Cr -54Cr -21Cr -267.39Cr -21Cr -20Cr -860.36Cr | -8.51Cr -7.42Cr -7.01Cr -6.37Cr -12Cr -817.04Cr -12Cr -84Cr -32Cr -415.39Cr -32Cr -31Cr -1.34TCr |
| Net Debt | -3.67Cr -3.2Cr -3.02Cr -2.75Cr -5.14Cr -352.37Cr -5.17Cr -36Cr -14Cr -179.15Cr -14Cr -13Cr -576.43Cr | -2.4Cr -2.09Cr -1.97Cr -1.79Cr -3.36Cr -230.13Cr -3.37Cr -24Cr -9.13Cr -117Cr -9.01Cr -8.81Cr -376.46Cr |
Employees
163
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SCPH Stock
Select your edition
All financial news and data tailored to specific country editions
